25 XP   0   0   10

Unichem Laboratories Limited
Buy, Hold or Sell?

Let's analyse Unichem Laboratories Limited together

PenkeI guess you are interested in Unichem Laboratories Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Unichem Laboratories Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Unichem Laboratories Limited

I send you an email if I find something interesting about Unichem Laboratories Limited.

Quick analysis of Unichem Laboratories Limited (30 sec.)










What can you expect buying and holding a share of Unichem Laboratories Limited? (30 sec.)

How much money do you get?

How much money do you get?
INR0.19
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR345.90
Expected worth in 1 year
INR245.52
How sure are you?
80.0%

+ What do you gain per year?

Total Gains per Share
INR-84.32
Return On Investment
-15.3%

For what price can you sell your share?

Current Price per Share
INR549.70
Expected price per share
INR480.00 - INR572.00
How sure are you?
50%

1. Valuation of Unichem Laboratories Limited (5 min.)




Live pricePrice per Share (EOD)

INR549.70

Intrinsic Value Per Share

INR-444.46 - INR264.39

Total Value Per Share

INR-98.57 - INR610.28

2. Growth of Unichem Laboratories Limited (5 min.)




Is Unichem Laboratories Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$292.2m$314.2m-$21.9m-7.5%

How much money is Unichem Laboratories Limited making?

Current yearPrevious yearGrowGrow %
Making money-$24.2m$3.9m-$28.2m-116.3%
Net Profit Margin-15.1%2.6%--

How much money comes from the company's main activities?

3. Financial Health of Unichem Laboratories Limited (5 min.)




What can you expect buying and holding a share of Unichem Laboratories Limited? (5 min.)

Welcome investor! Unichem Laboratories Limited's management wants to use your money to grow the business. In return you get a share of Unichem Laboratories Limited.

What can you expect buying and holding a share of Unichem Laboratories Limited?

First you should know what it really means to hold a share of Unichem Laboratories Limited. And how you can make/lose money.

Speculation

The Price per Share of Unichem Laboratories Limited is INR549.70. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Unichem Laboratories Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Unichem Laboratories Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR345.90. Based on the TTM, the Book Value Change Per Share is INR-25.09 per quarter. Based on the YOY, the Book Value Change Per Share is INR7.83 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR4.01 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Unichem Laboratories Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.34-0.1%-0.34-0.1%0.060.0%-0.070.0%0.360.1%
Usd Book Value Change Per Share-0.30-0.1%-0.30-0.1%0.090.0%0.120.0%0.320.1%
Usd Dividend Per Share0.050.0%0.050.0%0.050.0%0.060.0%0.050.0%
Usd Total Gains Per Share-0.250.0%-0.250.0%0.140.0%0.180.0%0.370.1%
Usd Price Per Share3.48-3.48-3.12-2.91-2.92-
Price to Earnings Ratio-10.09--10.09-55.48-6.66-11.38-
Price-to-Total Gains Ratio-13.74--13.74-21.93-6.16-10.68-
Price to Book Ratio0.84-0.84-0.70-0.67-1.36-
Price-to-Total Gains Ratio-13.74--13.74-21.93-6.16-10.68-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.5964
Number of shares151
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.06
Usd Book Value Change Per Share-0.300.12
Usd Total Gains Per Share-0.250.18
Gains per Quarter (151 shares)-38.2026.65
Gains per Year (151 shares)-152.79106.60
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
129-182-163337397
258-364-31667147204
387-546-469100220311
4116-728-622133293418
5145-909-775166367525
6175-1091-928200440632
7204-1273-1081233513739
8233-1455-1234266587846
9262-1637-1387299660953
10291-1819-15403337331060

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%2.03.00.040.0%7.03.00.070.0%15.03.00.083.3%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%16.02.00.088.9%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%18.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%3.02.00.060.0%8.02.00.080.0%16.02.00.088.9%

Fundamentals of Unichem Laboratories Limited

About Unichem Laboratories Limited

Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products worldwide. It offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management; and active pharmaceutical ingredients, as well as contract manufacturing services. The company also manufactures allopathic medicines, bulk drugs, and chemicals. Unichem Laboratories Limited was founded in 1944 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-04-14 10:14:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Unichem Laboratories Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Unichem Laboratories Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -15.1% means that ₹-0.15 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Unichem Laboratories Limited:

  • The MRQ is -15.1%. The company is making a huge loss. -2
  • The TTM is -15.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-15.1%TTM-15.1%0.0%
TTM-15.1%YOY2.6%-17.7%
TTM-15.1%5Y-3.4%-11.7%
5Y-3.4%10Y34.4%-37.7%
1.1.2. Return on Assets

Shows how efficient Unichem Laboratories Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -6.3% Return on Assets means that Unichem Laboratories Limited generated ₹-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Unichem Laboratories Limited:

  • The MRQ is -6.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-6.3%TTM-6.3%0.0%
TTM-6.3%YOY1.0%-7.3%
TTM-6.3%5Y-1.4%-5.0%
5Y-1.4%10Y11.0%-12.3%
1.1.3. Return on Equity

Shows how efficient Unichem Laboratories Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.3% Return on Equity means Unichem Laboratories Limited generated ₹-0.08 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Unichem Laboratories Limited:

  • The MRQ is -8.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-8.3%0.0%
TTM-8.3%YOY1.3%-9.6%
TTM-8.3%5Y-1.8%-6.5%
5Y-1.8%10Y13.7%-15.5%

1.2. Operating Efficiency of Unichem Laboratories Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Unichem Laboratories Limited is operating .

  • Measures how much profit Unichem Laboratories Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of -11.2% means the company generated ₹-0.11  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Unichem Laboratories Limited:

  • The MRQ is -11.2%. The company is operating very inefficient. -2
  • The TTM is -11.2%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-11.2%TTM-11.2%0.0%
TTM-11.2%YOY2.5%-13.7%
TTM-11.2%5Y-3.3%-7.9%
5Y-3.3%10Y35.4%-38.7%
1.2.2. Operating Ratio

Measures how efficient Unichem Laboratories Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.14 means that the operating costs are ₹1.14 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of Unichem Laboratories Limited:

  • The MRQ is 1.141. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.141. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.141TTM1.1410.000
TTM1.141YOY1.009+0.132
TTM1.1415Y1.076+0.065
5Y1.07610Y1.026+0.050

1.3. Liquidity of Unichem Laboratories Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Unichem Laboratories Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.48 means the company has ₹2.48 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of Unichem Laboratories Limited:

  • The MRQ is 2.484. The company is able to pay all its short-term debts. +1
  • The TTM is 2.484. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.484TTM2.4840.000
TTM2.484YOY2.979-0.496
TTM2.4845Y3.043-0.559
5Y3.04310Y2.983+0.060
1.3.2. Quick Ratio

Measures if Unichem Laboratories Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.22 means the company can pay off ₹1.22 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Unichem Laboratories Limited:

  • The MRQ is 1.223. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.223. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.223TTM1.2230.000
TTM1.223YOY2.060-0.837
TTM1.2235Y2.452-1.229
5Y2.45210Y2.305+0.147

1.4. Solvency of Unichem Laboratories Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Unichem Laboratories Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Unichem Laboratories Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.24 means that Unichem Laboratories Limited assets are financed with 23.7% credit (debt) and the remaining percentage (100% - 23.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Unichem Laboratories Limited:

  • The MRQ is 0.237. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.237. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.237TTM0.2370.000
TTM0.237YOY0.211+0.026
TTM0.2375Y0.199+0.039
5Y0.19910Y0.226-0.027
1.4.2. Debt to Equity Ratio

Measures if Unichem Laboratories Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 31.1% means that company has ₹0.31 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Unichem Laboratories Limited:

  • The MRQ is 0.311. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.311. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.311TTM0.3110.000
TTM0.311YOY0.267+0.044
TTM0.3115Y0.249+0.062
5Y0.24910Y0.296-0.047

2. Market Valuation of Unichem Laboratories Limited

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Unichem Laboratories Limited generates.

  • Above 15 is considered overpriced but always compare Unichem Laboratories Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -10.09 means the investor is paying ₹-10.09 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Unichem Laboratories Limited:

  • The EOD is -19.138. Based on the earnings, the company is expensive. -2
  • The MRQ is -10.086. Based on the earnings, the company is expensive. -2
  • The TTM is -10.086. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-19.138MRQ-10.086-9.052
MRQ-10.086TTM-10.0860.000
TTM-10.086YOY55.483-65.569
TTM-10.0865Y6.661-16.747
5Y6.66110Y11.380-4.719
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Unichem Laboratories Limited:

  • The EOD is -29.907. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.762. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -15.762. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-29.907MRQ-15.762-14.146
MRQ-15.762TTM-15.7620.000
TTM-15.762YOY-4.745-11.017
TTM-15.7625Y-6.942-8.819
5Y-6.94210Y-343.258+336.315
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Unichem Laboratories Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.84 means the investor is paying ₹0.84 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of Unichem Laboratories Limited:

  • The EOD is 1.589. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.838. Based on the equity, the company is cheap. +2
  • The TTM is 0.838. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.589MRQ0.838+0.752
MRQ0.838TTM0.8380.000
TTM0.838YOY0.701+0.137
TTM0.8385Y0.670+0.168
5Y0.67010Y1.356-0.686
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Unichem Laboratories Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---25.094-25.0940%7.833-420%10.117-348%26.574-194%
Book Value Per Share--345.895345.8950%370.989-7%362.339-5%251.403+38%
Current Ratio--2.4842.4840%2.979-17%3.043-18%2.983-17%
Debt To Asset Ratio--0.2370.2370%0.211+12%0.199+19%0.226+5%
Debt To Equity Ratio--0.3110.3110%0.267+16%0.249+25%0.296+5%
Dividend Per Share--4.0134.0130%4.0180%4.590-13%4.296-7%
Eps---28.723-28.7230%4.684-713%-6.218-78%30.006-196%
Free Cash Flow Per Share---18.380-18.3800%-54.777+198%-47.104+156%-27.970+52%
Free Cash Flow To Equity Per Share---29.927-29.9270%-27.683-7%-49.276+65%-40.085+34%
Gross Profit Margin--1.6411.6410%-2.650+262%2.083-21%1.331+23%
Intrinsic Value_10Y_max--264.387--------
Intrinsic Value_10Y_min---444.465--------
Intrinsic Value_1Y_max---16.264--------
Intrinsic Value_1Y_min---46.933--------
Intrinsic Value_3Y_max---16.281--------
Intrinsic Value_3Y_min---139.777--------
Intrinsic Value_5Y_max--22.988--------
Intrinsic Value_5Y_min---230.551--------
Market Cap38702068260.000+47%20396560260.00020396560260.0000%18343516666.700+11%17056366203.340+20%19674569905.525+4%
Net Profit Margin---0.151-0.1510%0.026-668%-0.034-78%0.344-144%
Operating Margin---0.112-0.1120%0.025-547%-0.033-71%0.354-132%
Operating Ratio--1.1411.1410%1.009+13%1.076+6%1.026+11%
Pb Ratio1.589+47%0.8380.8380%0.701+20%0.670+25%1.356-38%
Pe Ratio-19.138-90%-10.086-10.0860%55.483-118%6.661-251%11.380-189%
Price Per Share549.700+47%289.700289.7000%259.900+11%242.130+20%243.665+19%
Price To Free Cash Flow Ratio-29.907-90%-15.762-15.7620%-4.745-70%-6.942-56%-343.258+2078%
Price To Total Gains Ratio-26.076-90%-13.742-13.7420%21.931-163%6.161-323%10.676-229%
Quick Ratio--1.2231.2230%2.060-41%2.452-50%2.305-47%
Return On Assets---0.063-0.0630%0.010-736%-0.014-78%0.110-158%
Return On Equity---0.083-0.0830%0.013-758%-0.018-78%0.137-161%
Total Gains Per Share---21.081-21.0810%11.851-278%14.708-243%30.871-168%
Usd Book Value--292236492.000292236492.0000%314209320.000-7%306283404.000-5%229733721.600+27%
Usd Book Value Change Per Share---0.301-0.3010%0.094-420%0.121-348%0.319-194%
Usd Book Value Per Share--4.1514.1510%4.452-7%4.348-5%3.017+38%
Usd Dividend Per Share--0.0480.0480%0.0480%0.055-13%0.052-7%
Usd Eps---0.345-0.3450%0.056-713%-0.075-78%0.360-196%
Usd Free Cash Flow---15528768.000-15528768.0000%-46393728.000+199%-39819571.200+156%-24724792.800+59%
Usd Free Cash Flow Per Share---0.221-0.2210%-0.657+198%-0.565+156%-0.336+52%
Usd Free Cash Flow To Equity Per Share---0.359-0.3590%-0.332-7%-0.591+65%-0.481+34%
Usd Market Cap464424819.120+47%244758723.120244758723.1200%220122200.000+11%204676394.440+20%236094838.866+4%
Usd Price Per Share6.596+47%3.4763.4760%3.119+11%2.906+20%2.924+19%
Usd Profit---24267312.000-24267312.0000%3967404.000-712%-5251776.000-78%33449917.200-173%
Usd Revenue--161162664.000161162664.0000%149757840.000+8%145444442.400+11%144418753.200+12%
Usd Total Gains Per Share---0.253-0.2530%0.142-278%0.176-243%0.370-168%
 EOD+5 -3MRQTTM+0 -0YOY+10 -265Y+11 -2510Y+15 -21

3.2. Fundamental Score

Let's check the fundamental score of Unichem Laboratories Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-19.138
Price to Book Ratio (EOD)Between0-11.589
Net Profit Margin (MRQ)Greater than0-0.151
Operating Margin (MRQ)Greater than0-0.112
Quick Ratio (MRQ)Greater than11.223
Current Ratio (MRQ)Greater than12.484
Debt to Asset Ratio (MRQ)Less than10.237
Debt to Equity Ratio (MRQ)Less than10.311
Return on Equity (MRQ)Greater than0.15-0.083
Return on Assets (MRQ)Greater than0.05-0.063
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Unichem Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose505.000
Total0/1 (0.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-03-312020-03-312021-03-312022-03-312023-03-31
EBITDA  21,525130,266151,7911,140,6871,292,478-66,7761,225,702-1,597,373-371,671
Total Other Income Expense Net 762,56961,221823,790-381,751442,039-110,997331,042-588,563-257,521



Latest Balance Sheet

Balance Sheet of 2023-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets31,930,489
Total Liabilities7,577,448
Total Stockholder Equity24,353,041
 As reported
Total Liabilities 7,577,448
Total Stockholder Equity+ 24,353,041
Total Assets = 31,930,489

Assets

Total Assets31,930,489
Total Current Assets15,884,651
Long-term Assets16,045,838
Total Current Assets
Cash And Cash Equivalents 1,837,522
Short-term Investments 48,532
Net Receivables 5,886,779
Inventory 6,252,293
Other Current Assets 1,859,525
Total Current Assets  (as reported)15,884,651
Total Current Assets  (calculated)15,884,651
+/-0
Long-term Assets
Property Plant Equipment 14,025,700
Goodwill 15,451
Intangible Assets 15,451
Long-term Assets Other 1,887,326
Long-term Assets  (as reported)16,045,838
Long-term Assets  (calculated)15,943,928
+/- 101,910

Liabilities & Shareholders' Equity

Total Current Liabilities6,396,008
Long-term Liabilities1,181,440
Total Stockholder Equity24,353,041
Total Current Liabilities
Short-term Debt 2,389,030
Short Long Term Debt 2,337,435
Accounts payable 2,906,860
Other Current Liabilities 518,943
Total Current Liabilities  (as reported)6,396,008
Total Current Liabilities  (calculated)8,152,268
+/- 1,756,260
Long-term Liabilities
Long term Debt Total 751,421
Capital Lease Obligations 166,526
Long-term Liabilities Other 10,950
Long-term Liabilities  (as reported)1,181,440
Long-term Liabilities  (calculated)928,897
+/- 252,543
Total Stockholder Equity
Common Stock140,812
Retained Earnings 23,975,054
Accumulated Other Comprehensive Income 223,873
Capital Surplus 13,302
Total Stockholder Equity (as reported)24,353,041
Total Stockholder Equity (calculated)24,353,041
+/-0
Other
Capital Stock140,812
Cash And Equivalents1,500,354
Cash and Short Term Investments 1,886,054
Common Stock Shares Outstanding 70,406
Current Deferred Revenue581,175
Liabilities and Stockholders Equity 31,930,489
Net Debt 1,302,929
Net Invested Capital 27,326,966
Net Working Capital 9,488,643
Property Plant and Equipment Gross 14,025,700
Short Long Term Debt Total 3,140,451



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-31
> Total Assets 
5,092,580
5,949,660
6,029,430
7,028,419
8,006,491
8,812,950
9,865,506
10,725,029
11,446,538
11,686,768
12,842,662
15,257,634
31,889,737
31,496,115
31,447,359
31,257,140
33,187,743
31,930,489
31,930,48933,187,74331,257,14031,447,35931,496,11531,889,73715,257,63412,842,66211,686,76811,446,53810,725,0299,865,5068,812,9508,006,4917,028,4196,029,4305,949,6605,092,580
   > Total Current Assets 
2,907,480
2,977,080
2,614,610
3,250,787
3,444,608
4,035,474
4,393,457
4,784,419
5,806,831
5,644,201
5,979,359
7,598,191
23,317,754
20,384,142
16,864,662
13,773,166
16,449,247
15,884,651
15,884,65116,449,24713,773,16616,864,66220,384,14223,317,7547,598,1915,979,3595,644,2015,806,8314,784,4194,393,4574,035,4743,444,6083,250,7872,614,6102,977,0802,907,480
       Cash And Cash Equivalents 
864,290
271,860
100,550
343,696
236,393
151,602
232,333
246,386
521,503
269,621
201,261
161,377
6,664,043
1,970,467
2,262,199
774,608
1,091,963
1,837,522
1,837,5221,091,963774,6082,262,1991,970,4676,664,043161,377201,261269,621521,503246,386232,333151,602236,393343,696100,550271,860864,290
       Short-term Investments 
329,620
444,710
282,040
357,313
443,783
524,289
145,000
330,604
56,698
350,392
80,000
241,823
9,106,073
8,023,254
4,191,022
2,364,292
2,635,802
48,532
48,5322,635,8022,364,2924,191,0228,023,2549,106,073241,82380,000350,39256,698330,604145,000524,289443,783357,313282,040444,710329,620
       Net Receivables 
0
0
0
0
0
0
0
0
2,152,783
2,105,723
2,198,323
3,289,162
3,248,116
5,284,488
4,841,837
2,645,002
5,009,420
5,886,779
5,886,7795,009,4202,645,0024,841,8375,284,4883,248,1163,289,1622,198,3232,105,7232,152,78300000000
       Inventory 
697,950
844,610
832,760
1,033,881
1,094,684
1,502,624
1,579,641
1,430,457
2,034,940
2,076,797
2,305,706
2,817,109
2,728,644
3,386,646
3,965,410
5,383,398
6,002,215
6,252,293
6,252,2936,002,2155,383,3983,965,4103,386,6462,728,6442,817,1092,305,7062,076,7972,034,9401,430,4571,579,6411,502,6241,094,6841,033,881832,760844,610697,950
       Other Current Assets 
1,015,620
1,415,900
1,399,260
1,515,897
1,669,748
1,856,959
2,436,483
2,776,972
3,193,690
2,947,391
3,392,392
4,377,882
4,818,994
1,719,287
1,604,194
2,605,866
1,709,847
1,859,525
1,859,5251,709,8472,605,8661,604,1941,719,2874,818,9944,377,8823,392,3922,947,3913,193,6902,776,9722,436,4831,856,9591,669,7481,515,8971,399,2601,415,9001,015,620
   > Long-term Assets 
2,185,100
2,972,580
3,414,820
3,777,632
4,561,883
4,777,476
5,472,049
5,940,610
5,639,707
6,042,567
6,863,303
7,659,443
8,571,983
11,111,973
14,582,697
17,483,974
16,738,496
16,045,838
16,045,83816,738,49617,483,97414,582,69711,111,9738,571,9837,659,4436,863,3036,042,5675,639,7075,940,6105,472,0494,777,4764,561,8833,777,6323,414,8202,972,5802,185,100
       Property Plant Equipment 
1,989,210
2,742,480
3,398,460
3,751,824
3,954,224
4,548,771
5,052,029
5,669,004
5,066,948
5,355,875
6,378,823
7,377,879
8,105,946
8,968,871
11,949,814
14,463,738
14,823,032
14,025,700
14,025,70014,823,03214,463,73811,949,8148,968,8718,105,9467,377,8796,378,8235,355,8755,066,9485,669,0045,052,0294,548,7713,954,2243,751,8243,398,4602,742,4801,989,210
       Goodwill 
0
229,200
15,450
15,450
15,450
15,450
0
0
15,450
15,450
15,451
15,451
15,451
15,451
15,451
15,451
15,451
15,451
15,45115,45115,45115,45115,45115,45115,45115,45115,45015,4500015,45015,45015,45015,450229,2000
       Long Term Investments 
0
0
0
0
0
0
0
0
57,231
58,321
55,418
57,249
54,827
1,255,433
0
0
0
0
00001,255,43354,82757,24955,41858,32157,23100000000
       Intangible Assets 
130
130
150
150
107
67
159,495
0
15,902
15,004
23,788
31,884
4,610
2,455
15,451
15,451
15,451
15,451
15,45115,45115,45115,4512,4554,61031,88423,78815,00415,9020159,49567107150150130130
       Long-term Assets Other 
329,620
444,710
282,040
357,313
443,783
524,289
405,225
414,385
540,874
796,486
384,572
295,124
9,461,169
8,726,172
5,471,249
3,673,632
4,462,677
1,887,326
1,887,3264,462,6773,673,6325,471,2498,726,1729,461,169295,124384,572796,486540,874414,385405,225524,289443,783357,313282,040444,710329,620
> Total Liabilities 
1,621,050
1,925,720
1,914,220
2,183,949
2,377,361
2,635,901
3,259,673
3,454,310
3,280,446
3,011,566
3,294,306
4,621,439
5,088,899
5,297,046
6,133,842
5,688,792
7,003,633
7,577,448
7,577,4487,003,6335,688,7926,133,8425,297,0465,088,8994,621,4393,294,3063,011,5663,280,4463,454,3103,259,6732,635,9012,377,3612,183,9491,914,2201,925,7201,621,050
   > Total Current Liabilities 
1,087,510
1,379,360
1,348,370
1,462,998
1,672,741
1,757,531
2,332,970
2,511,213
2,303,202
2,117,640
2,431,953
3,917,391
4,635,140
5,029,178
5,667,265
5,057,611
5,521,277
6,396,008
6,396,0085,521,2775,057,6115,667,2655,029,1784,635,1403,917,3912,431,9532,117,6402,303,2022,511,2132,332,9701,757,5311,672,7411,462,9981,348,3701,379,3601,087,510
       Short-term Debt 
0
0
0
0
0
0
254,194
0
10,386
16,257
129,250
976,220
1,503,965
1,996,655
1,880,542
1,047,829
2,455,702
2,389,030
2,389,0302,455,7021,047,8291,880,5421,996,6551,503,965976,220129,25016,25710,3860254,194000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
256,837
219,718
359,057
976,220
1,503,965
1,996,655
1,840,336
1,006,250
2,413,518
2,337,435
2,337,4352,413,5181,006,2501,840,3361,996,6551,503,965976,220359,057219,718256,83700000000
       Accounts payable 
594,780
983,450
900,510
1,012,993
1,170,728
1,235,551
1,402,983
1,566,283
1,505,177
1,382,253
1,736,803
2,180,281
2,262,349
2,214,053
2,502,160
2,100,814
1,831,870
2,906,860
2,906,8601,831,8702,100,8142,502,1602,214,0532,262,3492,180,2811,736,8031,382,2531,505,1771,566,2831,402,9831,235,5511,170,7281,012,993900,510983,450594,780
       Other Current Liabilities 
492,730
395,910
447,860
450,005
502,013
521,980
675,793
944,930
787,639
719,130
565,900
752,929
822,701
797,049
263,154
566,250
526,537
518,943
518,943526,537566,250263,154797,049822,701752,929565,900719,130787,639944,930675,793521,980502,013450,005447,860395,910492,730
   > Long-term Liabilities 
533,540
546,360
565,850
720,951
704,620
878,370
926,703
943,097
977,244
893,926
862,353
704,048
453,759
267,868
466,577
631,181
1,482,356
1,181,440
1,181,4401,482,356631,181466,577267,868453,759704,048862,353893,926977,244943,097926,703878,370704,620720,951565,850546,360533,540
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
229,807
4,377
3,268
0
184,535
143,102
1,035,818
751,421
751,4211,035,818143,102184,53503,2684,377229,8070000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
730,793
690,465
631,986
699,671
497,412
267,868
282,042
488,079
446,538
0
0446,538488,079282,042267,868497,412699,671631,986690,465730,79300000000
> Total Stockholder Equity
3,257,770
4,023,940
4,115,210
4,844,470
5,629,130
6,177,049
6,605,833
7,270,719
8,166,092
8,675,202
9,548,356
10,636,195
26,800,838
26,199,069
25,313,517
25,568,348
26,184,110
24,353,041
24,353,04126,184,11025,568,34825,313,51726,199,06926,800,83810,636,1959,548,3568,675,2028,166,0927,270,7196,605,8336,177,0495,629,1304,844,4704,115,2104,023,9403,257,770
   Common Stock
180,020
180,170
180,210
180,275
180,315
180,479
180,643
180,913
181,255
181,538
181,687
181,753
140,674
140,767
140,812
140,812
140,812
140,812
140,812140,812140,812140,812140,767140,674181,753181,687181,538181,255180,913180,643180,479180,315180,275180,210180,170180,020
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 
-673,620
-783,420
-934,800
-1,119,930
-1,299,289
-1,584,018
-1,895,112
-2,238,545
-2,527,953
-2,918,440
-3,287,674
-733,809
-1,125,215
-1,657,351
-2,245,511
402,417
969,185
223,873
223,873969,185402,417-2,245,511-1,657,351-1,125,215-733,809-3,287,674-2,918,440-2,527,953-2,238,545-1,895,112-1,584,018-1,299,289-1,119,930-934,800-783,420-673,620
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
805,201
812,824
0
8,949
13,302
13,302
13,302
13,302
13,30213,30213,30213,3028,9490812,824805,2010000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
3,751,370
4,627,190
4,869,800
5,784,125
6,748,104
7,580,588
4,343,488
4,845,584
5,365,313
5,729,225
6,109,796
3,553,248
1,242,835
1,835,088
2,468,024
13,302
13,302
13,302
13,30213,30213,3022,468,0241,835,0881,242,8353,553,2486,109,7965,729,2255,365,3134,845,5844,343,4887,580,5886,748,1045,784,1254,869,8004,627,1903,751,370



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2023-03-31)

Gross Profit (+$)
totalRevenue13,430,222
Cost of Revenue-5,509,267
Gross Profit7,920,9557,920,955
 
Operating Income (+$)
Gross Profit7,920,955
Operating Expense-9,812,214
Operating Income-1,506,108-1,891,259
 
Operating Expense (+$)
Research Development263,939
Selling General Administrative333,221
Selling And Marketing Expenses1,295,568
Operating Expense9,812,2141,892,728
 
Net Interest Income (+$)
Interest Income173,125
Interest Expense-173,125
Other Finance Cost-173,125
Net Interest Income-173,125
 
Pretax Income (+$)
Operating Income-1,506,108
Net Interest Income-173,125
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,763,629-1,248,587
EBIT - interestExpense = -1,679,233
-1,763,629
-1,849,151
Interest Expense173,125
Earnings Before Interest and Taxes (EBIT)-1,506,108-1,590,504
Earnings Before Interest and Taxes (EBITDA)-371,671
 
After tax Income (+$)
Income Before Tax-1,763,629
Tax Provision-258,647
Net Income From Continuing Ops-2,022,276-2,022,276
Net Income-2,022,276
Net Income Applicable To Common Shares-2,022,276
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses15,321,481
Total Other Income/Expenses Net-257,521173,125
 

Technical Analysis of Unichem Laboratories Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Unichem Laboratories Limited. The general trend of Unichem Laboratories Limited is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Unichem Laboratories Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Unichem Laboratories Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 571.30 < 572.00.

The bearish price targets are: 529.45 > 481.95 > 480.00.

Tweet this
Unichem Laboratories Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Unichem Laboratories Limited. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Unichem Laboratories Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) ChartUnichem Laboratories Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Unichem Laboratories Limited. The current adx is .

Unichem Laboratories Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Relative Strength Index (RSI) ChartUnichem Laboratories Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Stochastic Oscillator ChartUnichem Laboratories Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Commodity Channel Index (CCI) ChartUnichem Laboratories Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Chande Momentum Oscillator (CMO) ChartUnichem Laboratories Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Williams %R ChartUnichem Laboratories Limited Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Average True Range (ATR) ChartUnichem Laboratories Limited Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily On-Balance Volume (OBV) ChartUnichem Laboratories Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Unichem Laboratories Limited.

Unichem Laboratories Limited Daily Money Flow Index (MFI) ChartUnichem Laboratories Limited Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Unichem Laboratories Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-06RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-01WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Unichem Laboratories Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Unichem Laboratories Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose505.000
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Unichem Laboratories Limited with someone you think should read this too:
  • Are you bullish or bearish on Unichem Laboratories Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Unichem Laboratories Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Unichem Laboratories Limited

I send you an email if I find something interesting about Unichem Laboratories Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Unichem Laboratories Limited.

Receive notifications about Unichem Laboratories Limited in your mailbox!